BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27283255)

  • 21. Dose-dependent association between muscle-strengthening activities and all-cause mortality: Prospective cohort study among a national sample of adults in the USA.
    Dankel SJ; Loenneke JP; Loprinzi PD
    Arch Cardiovasc Dis; 2016 Nov; 109(11):626-633. PubMed ID: 27591819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin therapy, muscle function and falls risk in community-dwelling older adults.
    Scott D; Blizzard L; Fell J; Jones G
    QJM; 2009 Sep; 102(9):625-33. PubMed ID: 19633029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular Effects of Rocuronium Bromide in Patients in Statin Therapy for at least Three Months.
    Ren H; Lv H
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):582-587. PubMed ID: 27234897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Per meal dose and frequency of protein consumption is associated with lean mass and muscle performance.
    Loenneke JP; Loprinzi PD; Murphy CH; Phillips SM
    Clin Nutr; 2016 Dec; 35(6):1506-1511. PubMed ID: 27086196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statin-associated muscle symptoms].
    Klose G
    MMW Fortschr Med; 2018 Jan; 160(1):40-43. PubMed ID: 29335944
    [No Abstract]   [Full Text] [Related]  

  • 27. Determining the Importance of Meeting Muscle-Strengthening Activity Guidelines: Is the Behavior or the Outcome of the Behavior (Strength) a More Important Determinant of All-Cause Mortality?
    Dankel SJ; Loenneke JP; Loprinzi PD
    Mayo Clin Proc; 2016 Feb; 91(2):166-74. PubMed ID: 26723715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-Specific Mortality Relative to Engagement in Muscle-Strengthening Activities and Lower Extremity Strength.
    Dankel SJ; Loenneke JP; Loprinzi PD
    J Phys Act Health; 2018 Feb; 15(2):144-149. PubMed ID: 28872397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study.
    Skarlovnik A; Janić M; Lunder M; Turk M; Šabovič M
    Med Sci Monit; 2014 Nov; 20():2183-8. PubMed ID: 25375075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin administration activates system xC
    Rebalka IA; Cao AW; May LL; Tarnopolsky MA; Hawke TJ
    Am J Physiol Cell Physiol; 2019 Nov; 317(5):C894-C899. PubMed ID: 31509447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participation in muscle-strengthening activities as an alternative method for the prevention of multimorbidity.
    Dankel SJ; Loenneke JP; Loprinzi PD
    Prev Med; 2015 Dec; 81():54-7. PubMed ID: 26264252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms.
    Taylor BA; Panza G; Thompson PD
    Int J Cardiol; 2016 Apr; 209():12-3. PubMed ID: 26874453
    [No Abstract]   [Full Text] [Related]  

  • 35. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
    Calza L; Magistrelli E; Colangeli V; Borderi M; Contadini I; Bon I; Re MC; Viale P
    AIDS; 2017 Mar; 31(5):681-688. PubMed ID: 28060020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.
    Chung HR; Vakil M; Munroe M; Parikh A; Meador BM; Wu PT; Jeong JH; Woods JA; Wilund KR; Boppart MD
    PLoS One; 2016; 11(12):e0168065. PubMed ID: 27936249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Associations of Muscle-Strengthening Activities and Accelerometer-Assessed Physical Activity on Multimorbidity: Findings From NHANES.
    Dankel SJ; Loenneke JP; Loprinzi PD
    Am J Health Promot; 2017 Jul; 31(4):274-277. PubMed ID: 26730562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of musculoskeletal pain and statin use.
    Buettner C; Davis RB; Leveille SG; Mittleman MA; Mukamal KJ
    J Gen Intern Med; 2008 Aug; 23(8):1182-6. PubMed ID: 18449611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people.
    Haerer W; Delbaere K; Bartlett H; Lord SR; Rowland J
    Intern Med J; 2012 Dec; 42(12):1329-34. PubMed ID: 22032261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between Low Back Pain and Muscle-strengthening Activity in U.S. Adults.
    Alnojeidi AH; Johnson TM; Richardson MR; Churilla JR
    Spine (Phila Pa 1976); 2017 Aug; 42(16):1220-1225. PubMed ID: 28045881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.